Our findings uncovered mechanistic insights and suggest a viable therapeutic strategy for <i>NOTCH3</i>-associated SVD/VaD, reinforcing the value of patient-specific iPSCs for disease modeling and potential drug discovery. This evidence concerns the gene NOTCH3 and snowflake vitreoretinal degeneration.